0
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Leucine rich α2 glycoprotein 1 derived from malignant pleural mesothelioma cells facilitates macrophage M2 phenotypes

, , , , , , , , & show all
Pages 136-145 | Received 25 Jan 2024, Accepted 11 Jul 2024, Published online: 21 Jul 2024

References

  • Pairon J-C, Laurent F, Rinaldo M, et al. Pleural plaques and the risk of pleural mesothelioma. J Natl Cancer Inst. 2013;105(4):293–301. doi:10.1093/jnci/djs513.
  • Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the north western cape province. Br J Ind Med. 1960;17(4):260–271. doi:10.1136/oem.17.4.260.
  • Karpathiou G, Stefanou D, Froudarakis ME. Pleural neoplastic pathology. Respir Med. 2015;109(8):931–943. doi:10.1016/j.rmed.2015.05.014.
  • Robinson BW, Musk AW, Lake RA. Malignant mesothelioma. Lancet. 2005;366(9483):397–408. doi:10.1016/S0140-6736(05)67025-0.
  • Kamp DW, Israbian VA, Preusen SE, Zhang CX, Weitzman SA. Asbestos causes DNA strand breaks in cultured pulmonary epithelial cells: role of iron-catalyzed free radicals. Am J Physiol. 1995;268(3 Pt 1):L471–L480. doi:10.1152/ajplung.1995.268.3.L471.
  • Sekido Y. Molecular pathogenesis of malignant mesothelioma. Carcinogenesis. 2013;34(7):1413–1419. doi:10.1093/carcin/bgt166.
  • Nishimura Y, Maeda M, Kumagai-Takei N, et al. Altered functions of alveolar macrophages and NK cells involved in asbestos-related diseases. Environ Health Prev Med. 2013;18(3):198–204. doi:10.1007/s12199-013-0333-y.
  • Sanchez VC, Pietruska JR, Miselis NR, Hurt RH, Kane AB. Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos? Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1(5):511–529. doi:10.1002/wnan.41.
  • Yang H, Bocchetta M, Kroczynska B, et al. TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci USA. 2006;103(27):10397–10402. doi:10.1073/pnas.0604008103.
  • Minnema-Luiting J, Vroman H, Aerts J, Cornelissen R. Heterogeneity in immune cell content in malignant pleural mesothelioma. Int J Mol Sci. 2018;19(4):1041. doi:10.3390/ijms19041041.
  • Hegmans JP, Hemmes A, Hammad H, Boon L, Hoogsteden HC, Lambrecht BN. Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses. Eur Respir J. 2006;27(6):1086–1095. doi:10.1183/09031936.06.00135305.
  • Salaroglio IC, Kopecka J, Napoli F, et al. Potential diagnostic and prognostic role of microenvironment in malignant pleural mesothelioma. J Thorac Oncol. 2019;14(8):1458–1471. doi:10.1016/j.jtho.2019.03.029.
  • Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci. 2008;13(13):453–461. doi:10.2741/2692.
  • Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment. Int J Mol Sci. 2021;22(13):6995. doi:10.3390/ijms22136995.
  • Liu J-J, Pek SLT, Liu S, et al. Association of plasma leucine-rich alpha-2 glycoprotein 1 (LRG1) with all-cause and cause-specific mortality in individuals with type 2 diabetes. Clin Chem. 2021;67(12):1640–1649. doi:10.1093/clinchem/hvab172.
  • Hong Q, Cai H, Zhang L, et al. Modulation of transforming growth factor-beta-induced kidney fibrosis by leucine-rich α-2 glycoprotein-1. Kidney Int. 2022;101(2):299–314. doi:10.1016/j.kint.2021.10.023.
  • Désage A-L, Karpathiou G, Peoc’h M, Froudarakis ME. The immune microenvironment of malignant pleural mesothelioma: a literature review. Cancers (Basel). 2021;13(13):13. doi:10.3390/cancers13133205.
  • Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 2008;320(5876):674–677. doi:10.1126/science.1156995.
  • Fishbein A, Hammock BD, Serhan CN, Panigrahy D. Carcinogenesis: failure of resolution of inflammation? Pharmacol Ther. 2021;218:107670. doi:10.1016/j.pharmthera.2020.107670.
  • Camilli C, Hoeh AE, De Rossi G, Moss SE, Greenwood J. LRG1: an emerging player in disease pathogenesis. J Biomed Sci. 2022;29(1):6. doi:10.1186/s12929-022-00790-6.
  • Shirai R, Hirano F, Ohkura N, Ikeda K, Inoue S. Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response. Biochem Biophys Res Commun. 2009;382(4):776–779. doi:10.1016/j.bbrc.2009.03.104.
  • Okabe Y, Medzhitov R. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell. 2014;157(4):832–844. doi:10.1016/j.cell.2014.04.016.